Jinhe Biotechnology Co., Ltd.
世界最大のクロルテトラサイクリン API 製造会社で、プレミックス動物飼料添加物も製造しています。
深セン証券取引所に上場している Jinhe Biotechnology は、発酵ベースの動物用健康製品の世界的リーダーです。同社は動物用 API、飼料グレードの抗生物質、プロバイオティクスを製造し、80 か国以上の飼料工場や動物衛生販売業者に販売しています。輸出比率60%以上。
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Hohhot, China
- Website
- jinhebio.com
- Categories
- 獣医製品と動物の健康, 飼料・粗飼料
- Markets
- アメリカ合衆国, ブラジル, インド, ベトナム
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- debarment-clear (green), checked 2026-08-12 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- domain-registered (green), checked 2026-08-12 Domain registry record
- lei-lapsed (amber), checked 2026-08-12 GLEIF
- sanctions-clear (green), checked 2026-08-12 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
Claimed certifications, not confirmed by us
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
- FDA Registered FDA Establishment Registration
Import rules for these goods
- Veterinary medicines sold in the EU need a marketing authorisation under Regulation (EU) 2019/6, and importers need a manufacturing/import authorisation. European Medicines Agency (veterinary)